EXSCEL Trademark

Trademark Overview

On Thursday, June 3, 2010, a trademark application was filed for EXSCEL with the United States Patent and Trademark Office. The USPTO has given the EXSCEL trademark a serial number of 85053846. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 23, 2018. This trademark is owned by Amylin Pharmaceuticals, Inc.. The EXSCEL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials for pharmaceutical preparations for the treatment of type 2 diabetes and their impact on cardiovascular disease
exscel

General Information

Serial Number85053846
Word MarkEXSCEL
Filing DateThursday, June 3, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 23, 2018
Registration Number3999509
Registration DateTuesday, July 19, 2011
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 22, 2011

Trademark Statements

Indication of Colors claimedThe color(s) purple, blue, and yellow is/are claimed as a feature of the mark.
Description of MarkThe mark consists of the word "EXSCEL" in all capital letters in the color purple. To the right of the word "EXSCEL" is a design image of a twisting band. The upper left and lower right side of the twisting band are in the color yellow, the upper right and lower left side of the twisting band are in the color blue, and the left and right side of the twisting band are in the color purple. The color white in the mark represents background/transparent areas and is not a part of the mark.
Goods and ServicesMedical and scientific research, namely, conducting clinical trials for pharmaceutical preparations for the treatment of type 2 diabetes and their impact on cardiovascular disease
Pseudo MarkEXCEL

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 23, 2018
Primary Code042
First Use Anywhere DateFriday, June 18, 2010
First Use In Commerce DateFriday, June 18, 2010

Trademark Owner History

Party NameAMYLIN PHARMACEUTICALS, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressSAN DIEGO, CA 92121
Party NameAmylin Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameAmylin Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameAmylin Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Friday, February 23, 2018CANCELLED SEC. 8 (6-YR)
Tuesday, July 19, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, March 24, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 24, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 29, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 29, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 31, 2012AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, July 19, 2011REGISTERED-PRINCIPAL REGISTER
Thursday, June 16, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, June 15, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, June 9, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, May 20, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 19, 2011STATEMENT OF USE PROCESSING COMPLETE
Tuesday, May 17, 2011USE AMENDMENT FILED
Thursday, May 19, 2011EXTENSION 1 GRANTED
Tuesday, May 17, 2011EXTENSION 1 FILED
Thursday, May 19, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 17, 2011TEAS EXTENSION RECEIVED
Tuesday, May 17, 2011TEAS STATEMENT OF USE RECEIVED
Tuesday, April 19, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 22, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 22, 2011PUBLISHED FOR OPPOSITION
Wednesday, January 19, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, January 18, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 18, 2011EXAMINER'S AMENDMENT ENTERED
Tuesday, January 18, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 18, 2011EXAMINERS AMENDMENT E-MAILED
Tuesday, January 18, 2011EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 29, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 29, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 29, 2010ASSIGNED TO LIE
Thursday, December 2, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 13, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 13, 2010NON-FINAL ACTION E-MAILED
Monday, September 13, 2010NON-FINAL ACTION WRITTEN
Wednesday, September 8, 2010ASSIGNED TO EXAMINER
Thursday, June 10, 2010NOTICE OF DESIGN SEARCH CODE MAILED
Wednesday, June 9, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 7, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

exscel diabetes type treatment their impact disease cardiovascular preparations pharmaceutical research